CYBN Valuation

Cybin Inc

Add to Watchlist

Advanced Chart

6.010

-0.23(-3.686%)1D

Overview
Forecast
Valuation
Earnings

CYBN Relative Valuation

CYBN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CYBN is overvalued; if below, it's undervalued.

Historical Valuation

Cybin Inc (CYBN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.08. The fair price of Cybin Inc (CYBN) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：5.96

Fair

-1.49

Trailing

Forward

-0.83

EV/EBITDA

Cybin Inc. (CYBN) has a current EV/EBITDA of -0.83. The 5-year average EV/EBITDA is -9.42. The thresholds are as follows: Strongly Undervalued below -30.31, Undervalued between -30.31 and -19.87, Fairly Valued between 1.03 and -19.87, Overvalued between 1.03 and 11.47, and Strongly Overvalued above 11.47. The current Forward EV/EBITDA of -0.83 falls within the Historic Trend Line -Fairly Valued range.

-0.66

EV/EBIT

Cybin Inc. (CYBN) has a current EV/EBIT of -0.66. The 5-year average EV/EBIT is -7.29. The thresholds are as follows: Strongly Undervalued below -21.73, Undervalued between -21.73 and -14.51, Fairly Valued between -0.08 and -14.51, Overvalued between -0.08 and 7.14, and Strongly Overvalued above 7.14. The current Forward EV/EBIT of -0.66 falls within the Historic Trend Line -Fairly Valued range.

0.00

Cybin Inc. (CYBN) has a current PS of 0.00. The 5-year average PS is 55.64. The thresholds are as follows: Strongly Undervalued below -410.38, Undervalued between -410.38 and -177.37, Fairly Valued between 288.65 and -177.37, Overvalued between 288.65 and 521.65, and Strongly Overvalued above 521.65. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-1.50

P/OCF

Cybin Inc. (CYBN) has a current P/OCF of -1.50. The 5-year average P/OCF is -10.44. The thresholds are as follows: Strongly Undervalued below -30.74, Undervalued between -30.74 and -20.59, Fairly Valued between -0.29 and -20.59, Overvalued between -0.29 and 9.86, and Strongly Overvalued above 9.86. The current Forward P/OCF of -1.50 falls within the Historic Trend Line -Fairly Valued range.

-1.50

P/FCF

Cybin Inc. (CYBN) has a current P/FCF of -1.50. The 5-year average P/FCF is -9.79. The thresholds are as follows: Strongly Undervalued below -28.59, Undervalued between -28.59 and -19.19, Fairly Valued between -0.39 and -19.19, Overvalued between -0.39 and 9.01, and Strongly Overvalued above 9.01. The current Forward P/FCF of -1.50 falls within the Historic Trend Line -Fairly Valued range.

Cybin Inc (CYBN) has a current Price-to-Book (P/B) ratio of 0.95. Compared to its 3-year average P/B ratio of 3.31 , the current P/B ratio is approximately -71.42% higher. Relative to its 5-year average P/B ratio of 200.83, the current P/B ratio is about -99.53% higher. Cybin Inc (CYBN) has a Forward Free Cash Flow (FCF) yield of approximately -48.40%. Compared to its 3-year average FCF yield of -26.38%, the current FCF yield is approximately 83.48% lower. Relative to its 5-year average FCF yield of -18.02% , the current FCF yield is about 168.59% lower.

0.91

P/B

Median3y

3.31

Median5y

200.83

-58.02

FCF Yield

Median3y

-26.38

Median5y

-18.02

Competitors Valuation Multiple

The average P/S ratio for CYBN's competitors is 0.01, providing a benchmark for relative valuation. Cybin Inc Corp (CYBN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Universe Pharmaceuticals Inc

Loss

2.11M

PBM.O

Psyence Biomedical Ltd

Performance Decomposition

Market capitalization of CYBN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of CYBN in the past 1 year is driven by Unknown.